SIMILARITY OF PHARMACOKINETICS AND SAFETY

Clinical trials for SIMILARITY OF PHARMACOKINETICS AND SAFETY explained in plain language.

Never miss a new study

Get alerted when new SIMILARITY OF PHARMACOKINETICS AND SAFETY trials appear

Sign up with your email to follow new studies for SIMILARITY OF PHARMACOKINETICS AND SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Early test for copycat allergy drug halted after one person

Knowledge-focused Terminated

This early-stage study aimed to see if a new drug called HS632 acts similarly in the body to an existing allergy medication, omalizumab (Xolair®). It involved giving a single injection to healthy male volunteers to compare how the drugs are processed and their safety. The trial w…

Matched conditions: SIMILARITY OF PHARMACOKINETICS AND SAFETY

Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Knowledge-focused

Last updated Mar 31, 2026 12:12 UTC

SIMILARITY OF PHARMACOKINETICS AND SAFETY

Get alerted when new SIMILARITY OF PHARMACOKINETICS AND SAFETY trials appear

Early test for copycat allergy drug halted after one person